Physician profile
John L Ledbetter
NPI 1225069065
$3,648.25
in general payments reported to CMS, 2019-2025
29 companies · $988 in 2025
The $988 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $422 · 2021: $167 · 2022: $144 · 2023: $200 · 2024: $1,233 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355 · Travel and Lodging: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.25 |
| Travel and Lodging | $1,066.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,641.64 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Nevro Corp. | $462.55 | 2019-2022 | |
| Horizon Therapeutics Plc | $219.82 | 2019-2022 | |
| Vertos Medical, INC. | $216.12 | 2023-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.35 | 2021-2024 | Relistor |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $94.89 | 2019-2020 | |
| Spr Therapeutics, INC | $93.00 | 2025 | Sprint Pns System |
| Amgen INC. | $78.22 | 2025 | Evenity |
| Stryker Corporation | $74.90 | 2022-2024 | Mild Device Kit |
| Medtronic, INC. | $60.86 | 2022-2025 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $58.26 | 2023-2024 | Evoke, Evoke Scs |
| Daiichi Sankyo INC. | $53.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Collegium Pharmaceutical, INC. | $44.01 | 2019-2024 | Belbuca |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $39.54 | 2023 | Intracept |
| Pacira Therapeutics, INC. | $39.36 | 2021 | |
| Interventional Pain Technologies INC. | $37.91 | 2021 | |
| Idorsia Pharmaceuticals US INC | $27.80 | 2022-2023 | Quviviq |
| Assertio Therapeutics, INC. | $21.80 | 2019 | |
| Radius Health, INC. | $19.17 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $15.84 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $15.02 | 2022 | |
| Grt US Holding, INC. | $14.43 | 2022 | |
| Medtronic USA, INC. | $13.05 | 2020 | |
| Stimwave Technologies Incorporated | $12.74 | 2020 | |
| Biodelivery Sciences International, INC. | $12.30 | 2021 | |
| Pfizer INC. | $12.29 | 2019 | |
| Fidia Pharma USA INC. | $8.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ledbetter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.